BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: McGinty G, Przemioslo R. Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implications. World J Gastroenterol 2024; 30(27): 3264-3267 [PMID: 39086753 DOI: 10.3748/wjg.v30.i27.3264]
URL: https://www.wjgnet.com/1949-8470/full/v30/i27/3264.htm
Number Citing Articles
1
Ling Luo, Congxiang Shao, Long Teng, Shuyu Zhuo, Zhi Dong, Wei Wang, Junzhao Ye, Bihui Zhong. Liver fibrosis with persistently normal alanine transaminase levels exhibits a distinct treatment response in MASLDBMJ Open Gastroenterology 2025; 12(1): e001895 doi: 10.1136/bmjgast-2025-001895
2
Terence N Moyana. Metabolic dysfunction-associated steatotic liver disease: The question of long-term high-normal alanine aminotransferase as a screening testWorld Journal of Gastroenterology 2024; 30(42): 4576-4582 doi: 10.3748/wjg.v30.i42.4576
3
Can Huang, Meng Chen, Yanfang Sun, Lin Zhang, Wei Liu. Research trends on the quality of life in patients with metabolic dysfunction-associated fatty liver diseases: a scientific metrology studyFrontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1689280